...and another good move....well done...
Given Metgasco’s confidence in the prospects for Byron and its securities, the Board has resolved that it is in the best interests of the Company’s shareholders that it retain its shares, and option to exercise its Entitlement rights, through to 11 December. Accordingly, its professional advisers have been instructed to pause work on relevant reports and tax ruling applications until the final quantum of BYE shares held by Metgasco is confirmed, on or before that date.Metgasco remains wholly committed to effecting an in-specie distribution of Byron shares to its shareholders. In accordance with the above timing, the Board advises shareholders that the necessary Extraordinary General Meeting to approve such distribution is now likely to be held in mid-late January.
- Forums
- ASX - By Stock
- MEL
- Ann: In-Specie Distribution of Byron Energy Shares - Update
MEL
metgasco ltd
Add to My Watchlist
0.00%
!
0.2¢

Ann: In-Specie Distribution of Byron Energy Shares - Update, page-2
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.665M |
Open | High | Low | Value | Volume |
0.2¢ | 0.2¢ | 0.2¢ | $2.284K | 1.142M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 19005694 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 11409690 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 19005694 | 0.002 |
8 | 35000998 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 10759690 | 12 |
0.004 | 10479052 | 6 |
0.006 | 311675 | 1 |
0.020 | 15085 | 1 |
0.022 | 91666 | 1 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
MEL (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online